By Drug Target Review2024-03-08T16:00:54
Understanding heart changes at the molecular level during early infection with adenovirus could enable identification of those at higher risk of arrhythmia.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-03-03T14:06:14
Sponsored by Bio-Techne
2024-01-19T07:40:55
Sponsored by Euretos
2023-07-11T16:13:06
Sponsored by Agilent
2023-01-06T10:25:33
Sponsored by Leica Microsystems
Site powered by Webvision Cloud